Delivery Order SPE2DB24D2212-SPE2DB25FHPVS

Award Date 5/21/25
Potential Completion Date 5/22/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML medical supplies. The $3,449.50 firm fixed-price Delivery Order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract has an ultimate completion date of January 27, 2025 and is not associated with any set-aside designation. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,653.15 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $1,872.64 for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 6, 2024. The award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA). The $4,639.10 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 5, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, for the delivery of the pharmaceutical product "TYPHIM VI 25 MCG/0.5 ML VIAL 10ML". The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a Delivery Order with a Firm Fixed Price of $7,114.87 and a completion date of April 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines to the Defense Logistics Agency (DLA). The $7,255.27 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of November 27, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,702.72 with a completion date of July 25, 2024. It is a Firm Fixed Price contract for the supply of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,808.93 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical vaccine product. The contract has a completion date of June 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $11,235.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical product, and is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,415.75 placed under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with an ultimate completion date of April 5, 2023. The contract has a Firm Fixed Price pricing type and was not designated with a set-aside requirement, indicating open...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB25FHPVS
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $8,632.90 for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract is a Firm Fixed Price arrangement with the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 22, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/20/25, 10:01 AM